Please use this identifier to cite or link to this item: http://dl.umsu.ac.ir/handle/Hannan/187727
Title: Monoclonal Antibodies for the Treatment of Nasal Polyps
Authors: Willson, Thomas J.;Naclerio, Robert M.;Lee, Stella E.
subject: Allergic rhinitis;Asthma;Biologics;Chronic rhinosinusitis;Nasal polyps
Year: 2017
Publisher: Elsevier Inc
Abstract: Biologics are novel therapeutic medications developed for the targeted therapy for a variety of inflammatory conditions. The biologics currently investigated for the treatment of chronic rhinosinusitis (CRS) with nasal polyps modulate specific inflammator
URI: http://dx.doi.org/10.1016/j.iac.2017.01.008
http://78.39.227.9/handle/Hannan/98292
http://dl.umsu.ac.ir/handle/Hannan/187727
ISSN: 9781416037033
volume: Volume 37
issue: Issue 2
month: May
Appears in Collections:Immunology and Allergy Clinics of North America 2017

Files in This Item:
File Description SizeFormat 
2017 IACNA Volume 37 Issue 2 May (10).pdf274.2 kBAdobe PDFThumbnail
Download    Request a copy


Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.